Medical device maker GE HealthCare said on Monday it would buy privately held Sofie Biosciences for $945 million in ​cash, in a move that strengthens its ability ‌to manufacture and distribute PET imaging drugs.

Log in or sign up to comment.

No comments yet.

← Back to stories